celastrol has been researched along with Fatty Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberobello, AT; Bagattin, A; Finkel, T; Gavrilova, O; Liu, J; Ma, X; Mueller, E; Skarulis, M; Xu, L | 1 |
| Choi, JW; Feng, X; Ibi, D; Lee, J; Liu, J; Mucka, P; Ozcan, U; Salazar Hernández, MA | 1 |
| Ridler, C | 1 |
3 other study(ies) available for celastrol and Fatty Liver
| Article | Year |
|---|---|
Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1α Transcriptional Axis.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Cells, Cultured; Diet, High-Fat; DNA-Binding Proteins; Energy Metabolism; Fatty Liver; Female; Heat Shock Transcription Factors; Humans; Liver; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Pentacyclic Triterpenes; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Promoter Regions, Genetic; Thermogenesis; Transcription Factors; Triglycerides; Triterpenes | 2015 |
Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Fatty Liver; Fluorescent Antibody Technique; Glucose Tolerance Test; Hypothalamus; Immunohistochemistry; Leptin; Liver; Mice; Mice, Obese; Obesity; Pentacyclic Triterpenes; Real-Time Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Triterpenes; Withanolides | 2016 |
Lipids: Celastrol protects against fatty liver through SIRT1.
Topics: Fatty Liver; Humans; Lipids; Liver; Pentacyclic Triterpenes; Sirtuin 1; Triterpenes | 2017 |